Cargando…

Predictive value of Tpeak-Tend interval for ventricular arrhythmia and mortality in heart failure patients with an implantable cardioverter-defibrillator: A cohort study

BACKGROUND: Tpeak-Tend interval (TpTe), a measurement of transmural dispersion of repolarization (TDR), has been shown to predict ventricular tachyarrhythmia in cardiac resynchronization therapy with defibrillator (CRT-D) patients. However, the ability of TpTe to predict ventricular tachyarrhythmia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Cong, Hua, Wei, Cai, Chi, Ding, Li-Gang, Niu, Hong-Xia, Fan, Xiao-Han, Liu, Zhi-Min, Gu, Min, Zhao, Yun-Zi, Zhang, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919476/ https://www.ncbi.nlm.nih.gov/pubmed/31804316 http://dx.doi.org/10.1097/MD.0000000000018080

Ejemplares similares

Sex and race differences in J-Tend, J-Tpeak, and Tpeak-Tend intervals
por: Hnatkova, Katerina, et al.
Publicado: (2019)

Tpeak-Tend, Tpeak-Tend dispersion and Tpeak-Tend/QT in children and its relationship with clinical variables
por: Castro-Torres, Yaniel, et al.
Publicado: (2019)

Acute and Chronic Changes and Predictive Value of Tpeak-Tend for Ventricular Arrhythmia Risk in Cardiac Resynchronization Therapy Patients
por: Xue, Cong, et al.
Publicado: (2016)

Tpeak-Tend Interval during Pregnancy and Postpartum
por: Kandzia, Tomasz, et al.
Publicado: (2022)

Common Genetic Variants Modulate the Electrocardiographic Tpeak-to-Tend Interval
por: Ramírez, Julia, et al.
Publicado: (2020)

Prognostic value of Tpeak-Tend interval in patients with acute pulmonary embolism
por: Icli, Abdullah, et al.
Publicado: (2015)

Relationship of the T-wave Tpeak-Tend interval with conduction system disorders in arterial hypertension
por: Candia, José C., et al.
Publicado: (2023)

Comorbid Hypertension Reduces the Risk of Ventricular Arrhythmia in Chronic Heart Failure Patients with Implantable Cardioverter-Defibrillators
por: Huang, Hao, et al.
Publicado: (2022)

Prognostic Value of Tpeak–Tend Interval in Early Diagnosis of Duchenne Muscular Dystrophy Cardiomyopathy
por: Baskan, Serra, et al.
Publicado: (2023)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
por: Römers, Hans, et al.
Publicado: (2022)

The relationship between length of stay in intensive care unit and Tpeak‐Tend and Tpeak‐Tend/QTc ratio in COVID 19 patients with acute coronary syndrome
por: Altuntas, Emine, et al.
Publicado: (2022)

QT and Tpeak‐Tend interval variability: Predictive electrical markers of hospital stay length and mortality in acute decompensated heart failure. Preliminary data
por: Piccirillo, Gianfranco, et al.
Publicado: (2022)

Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator
por: Back, Steven H, et al.
Publicado: (2019)

Impact of Myocardial Bridge on Life‐Threatening Ventricular Arrhythmia in Patients With Implantable Cardioverter Defibrillator
por: Okada, Kozo, et al.
Publicado: (2020)

Ventricular arrhythmias among patients with implantable cardioverter‐defibrillator during the COVID‐19 pandemic
por: Malanchini, G., et al.
Publicado: (2021)

Diffuse myocardial fibrosis associates with incident ventricular arrhythmia in implantable cardioverter defibrillator recipients
por: Olausson, Eric, et al.
Publicado: (2023)

Short‐Term Variability of the QT Interval Can be Used for the Prediction of Imminent Ventricular Arrhythmias in Patients With Primary Prophylactic Implantable Cardioverter Defibrillators
por: Smoczyńska, Agnieszka, et al.
Publicado: (2020)

Ventricular arrhythmia burden in patients with implantable cardioverter defibrillator and remote patient monitoring during different time intervals of the COVID-19 pandemic
por: Hauck, Christian, et al.
Publicado: (2022)

Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients
por: Zhou, You, et al.
Publicado: (2019)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
por: Noordman, Alwin B. P., et al.
Publicado: (2021)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
por: van der Lingen, Anne‐Lotte C.J., et al.
Publicado: (2021)

RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy
por: Tsukahara, Keita, et al.
Publicado: (2021)

Implantable cardioverter defibrillator as a treatment for massive left ventricular fibroma-induced ventricular arrhythmia in a child
por: Choi, In Su, et al.
Publicado: (2021)

Performance of an automated external cardioverter defibrillator for inhospital ventricular malignant arrhythmia
por: Timerman, S, et al.
Publicado: (2003)

Heart Rate Correction of the J-to-Tpeak Interval
por: Hnatkova, Katerina, et al.
Publicado: (2019)

Ventricular tachycardia as presenting arrhythmia as a determinant of appropriate implantable cardioverter-defibrillator therapy in secondary prevention
por: Noordman, A B P, et al.
Publicado: (2023)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Association left ventricular lead and ventricular arrhythmias after upgrade to cardiac resynchronization therapy in patients with implantable cardioverter defibrillators
por: Kawamura, Mitsuharu, et al.
Publicado: (2019)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Clinical Impact of Circulating Galectin-3 on Ventricular Arrhythmias and Heart Failure Hospitalization Independent of Prior Ventricular Arrhythmic Events in Patients with Implantable Cardioverter-defibrillators
por: Makimoto, Hisaki, et al.
Publicado: (2022)

Main air pollutants and ventricular arrhythmias in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis
por: Yang, Hong-Jie, et al.
Publicado: (2017)

Genome-Wide Association of Implantable Cardioverter-Defibrillator Activation With Life-Threatening Arrhythmias
por: Murray, Sarah S., et al.
Publicado: (2012)

Causes of Failure to Capture in Pacemakers and Implantable Cardioverter-defibrillators
por: Sabbagh, Ebrahim, et al.
Publicado: (2020)

Physical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator
por: Burch, Ashley E., et al.
Publicado: (2019)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Primary Prevention of Fatal Ventricular Arrhythmias With Implantable Cardioverter-Defibrillator Therapy – An Analysis of Implications Based on MADIT II Criteria
por: Carrim, Zia I, et al.
Publicado: (2006)

An interesting implantable cardioverter defibrillator treatment for lethal ventricular arrhythmias caused by coronary artery spasm: A case report
por: Sun, Jie, et al.
Publicado: (2017)

Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention patients
por: Zhou, You, et al.
Publicado: (2019)

Incidence of Ventricular Arrhythmias and 1‐Year Predictors of Mortality in Patients Treated With Implantable Cardioverter‐Defibrillator Undergoing Generator Replacement
por: Demarchi, Andrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3i0kc4q3nat45mtiq03d0nideu